Skip to main content

Table 3 Incidence of central nervous system metastasis as the only manifestation of disease progression according to the stage of disease

From: Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status

  CNS relapses (n = 40) P value
  Group A (n = 32) Group B (n = 8)  
Stage I/stage II 6 (15%) 3 (7.5%) 0.367
Stage IIIb/stage IV 26 (65%) 5 (12.5%) 0.143
All stages 32 (80%) 8 (20%) 0.048
  1. Group A, patients with breast cancer treated with a taxane-containing regimen; group B, patients with breast cancer treated with a nontaxane-containing regimen.